ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Cardiovascular Mortality Associated with Abnormal Calcium Metabolism

This study is no longer recruiting patients.

Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs

Purpose

The purpose of this cohort study is to estimate the risk of cardiovascular mortality associated with abnormal calcium metabolism

Condition
Cardiovascular Disease
Kidney Disease

MedlinePlus related topics:  Circulatory Disorders;   Heart Diseases;   Kidney Diseases

Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Retrospective/Prospective Study

Further Study Details: 

Study start: August 1997;  Study completion: June 2002

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

All ESRD patients who indicated dialysis in 1990-1993

Location Information


Washington
      VA Puget Sound Health Care System, Seattle,  Washington,  98108,  United States

More Information

Study ID Numbers:  CADE-AI
Record last reviewed:  June 2001
Record first received:  July 3, 2001
ClinicalTrials.gov Identifier:  NCT00018395
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-16
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act